Newsroom

Interview

"Infections and Drugs" is one of four research topics of the Technische Universität Braunschweig. This positions TU Braunschweig as a close partner of the HZI. Their cooperation was the basis of the Systems Biology Centre BRICS that was established jointly in 2011. In an InFact interview, BRICS speaker Dieter Jahn, who is a professor of microbiology, explains how the TU Braunschweig and the HZI may benefit from each other in the long term.

16.04.2018

BRICS

AESDarstellung des Fingerabdrucks der Genexpression jeder einzelnen Zelle in einer dreidimensionalen Projektion nach bioinformatischer Analyse zur Identifizierung des jeweiligen Zellphänotyps.

News

Stroke and heart attack are the leading cause of death in the Western world. Würzburg scientists have used a special technique to get a clearer picture of the cells involved and their activity. They present their results in the journal Circulation Research.

22.03.2018

HIRI

News

Humans are constantly exposed to pathogens like bacteria and viruses. In most cases, the immune system successfully detects and eliminates these invaders. However, the herpesvirus family has adapted brilliantly to the immune system: its members manage to stay in the host’s body for life after infection. A research team at the Helmholtz Centre for Infection Research (HZI) recently discovered that a protein of the carcinogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) commandeers an immune system component for its own benefit. This enables the virus to successfully infect its host. The researchers have published their results in the peer-reviewed journal PLOS Pathogens.

14.03.2018

HZI Campus

Bakterien der Art Pseudomonas aeruginosa sind äußerst widerstandfähig und kommen fast überall vor.

News

Pseudomonas aeruginosa bacteria are hospital germs and are often resistant to common antibiotics. They can infect all human organs and implants, and can persist in the body for long periods of time in a densely agglomerated community – a so-called biofilm. Agglomeration in the biofilm protects them from the immune system and even shields them from the effect of antibiotics. Scientists of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) recently developed a molecule that suppresses the production of biofilms by Pseudomonas. The molecule has another crucial benefit: Due to its small size, it is suitable for oral intake, unlike other drugs of this type. The scientists published their results in Journal of the American Chemical Society. The editors of the journal selected the article as their lead story because of the significance of its findings ("Editor's Choice"). The selection was associated with free-of-charge publication and free access ("Open Access"). The HIPS is a branch of the Helmholtz Centre for Infection Research (HZI), operated in cooperation with the Saarland University and, being a part of the HZI, also is part of the German Center for Infection Research (DZIF).

06.03.2018

HIPS

News

Time and again – the flu is coming to Germany. The number of cases of the current wave of influenza is still rising. When influenza viruses – the cause of the flu – enter our body, the immune system recognises them as being foreign by means of various receptors and starts a defence programme. Scientists of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and of the Otto von Guericke University Magdeburg recently studied the detailed role of a certain receptor in this first line of defence. They discovered that the receptor activates natural killer cells, which use messenger substances to activate other immune cells and then eliminate body cells that are infected by viruses. Deciphering these relationships can reveal new pathways for improvements in the prevention and therapy of influenza infections. The scientists published their results in Frontiers in Immunology.

21.02.2018

HZI Campus

Die grüne Immunfärbung des Hepatitis E Virus Kapsidproteins in den Plazentazellen weist die Replikation des Virus in diesen nach.

News

Hepatitis E virus infections are usually subclinical and are considered as an underrated disease by physicians. The number of infections worldwide is estimated at 20 million infected people per year. In our latitudes, primarily people with weakened immune systems get sick. In Asia and Africa, however, a different genotype is present, which is a serious threat to a very special population group: pregnant women. One in four pregnant women dies there as a result of a hepatitis E infection. Scientists at TWINCORE have now investigated the differences in regional hepatitis E types in order to explore treatment approaches against this highly dangerous variant for pregnant women. With their investigations, they first developed a cell model with which they can test drugs for their suitability against hepatitis E. The project was funded by the German Center for Infection Research (DZIF).

09.02.2018

TWINCORE

Back to the first page
...
80
81
82
83
...
150

HZI in the media

Dr. Rolf Müller, Managing Director of Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were both named laureates of the

22.12.2025

Research Information

... ein Interview mit Josef Penninger geführt . Er ist wissenschaftlicher Geschäftsführer des Helmholtz-Zentrum für Infektionsforschung in ...

21.12.2025

T3N

Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

19.12.2025

healthcare-in-europe.com

Biosyntheseweg aufzuklären. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit ...

18.12.2025

Bionity.COM

Finanzierungsmöglichkeiten fehlen.

Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz-Zentrums für Infektionsforschung (HZI)

16.12.2025

MedMedia

Korte from the Technical University of Braunschweig and the Helmholtz Centre for Infection Research (HZI).

The research was carried out as

12.12.2025

The Hindu

... des Leibniz Lungenzentrums Borstel, des Helmholtz-Instituts für Pharmazeutische Forschung Saarland sowie weiterer wissenschaftlicher ...

12.12.2025

Bionity.COM

Einrichtungen des regionalen Forschungsökosystems – darunter das Helmholtz-Zentrum für Infektionsforschung (HZI), das Deutsche Zentrum für

12.12.2025

EUROPE SAYS

Korte of the Technical University of Braunschweig and the Helmholtz Centre for Infection Research (HZI). The findings emerged from the

12.12.2025

The New Indian Express

Universität Würzburg. Seit 2018: Postdoc am Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), Entwicklung Bayes’scher ...

12.12.2025

BIOspektrum

Center Borstel - Leibniz Lung Center, the Helmholtz Institute for Pharmaceutical Research Saarland and other scientific institutions in

11.12.2025

Technology Networks

von Humboldt professor, head of department at the Helmholtz Centre for Infection Research, Braunschweig and full professor at the Hannover

10.12.2025

European Research Council

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.